MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX)
Keyword(s):
2013 ◽
2015 ◽
Keyword(s):
2014 ◽
Vol 115
(7)
◽
pp. 1254-1261
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. e15220-e15220
2014 ◽